Onderneming Karolinska Development AB
Aandelen
KDEV
SE0002190926
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,518 SEK | -0,13% | -2,32% | -10,60% |
Vakgebied
Aantal werknemers: 8
Verkoop per activiteit
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -12,43% |
Verkoop per regio
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -12,43% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Viktor Drvota
CEO | Chief Executive Officer | 59 | 07-12-15 |
Director of Finance/CFO | 56 | 01-10-22 | |
John Öhd
CTO | Chief Tech/Sci/R&D Officer | 53 | 01-06-20 |
Chief Investment Officer | 58 | 01-03-21 | |
Linda Spahiu
PRN | Corporate Officer/Principal | 39 | - |
Johan Dighed
LAW | General Counsel | 51 | 01-05-20 |
Corporate Officer/Principal | 59 | 01-11-15 | |
Eva Montgomerie
AUD | Comptroller/Controller/Auditor | 66 | 01-01-07 |
Thomas Andersson
PRN | Corporate Officer/Principal | 72 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Björn Cochlovius
CHM | Chairman | 56 | 01-01-20 |
Viktor Drvota
CEO | Chief Executive Officer | 59 | 07-12-15 |
Director/Board Member | 55 | 19-02-21 | |
Benjamin Toogood
BRD | Director/Board Member | 48 | 19-02-21 |
Theresa Tse
BRD | Director/Board Member | 32 | 28-11-17 |
Philip Duong
BRD | Director/Board Member | 34 | 12-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 10 | 2 555 261 | 0 | 0 | 35,96 % |
Aandeel B | 1 | 267 522 333 | 97 108 178 ( 36,30 %) | 244 285 ( 0,0913 %) |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
OSSDSIGN AB 9.83% | 9 596 662 | 9.83% | 9 064 815 $ |
Bedrijfsgegevens
Karolinska Development AB
Tomtebodavägen 23 A
171 65, Solna
+46 8 52 48 60 70
http://www.karolinskadevelopment.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. |
Biotechnology
|
Sector
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,60% | 37,54 mln. | |
-2,53% | 186 mld. | |
-3,52% | 106 mld. | |
-3,98% | 67,64 mld. | |
+5,33% | 50,39 mld. | |
+16,43% | 47,65 mld. | |
-1,73% | 39,29 mld. | |
+5,66% | 27,24 mld. | |
-2,01% | 25,42 mld. | |
-1,87% | 24,54 mld. |
- Beurs
- Aandelen
- Koers KDEV
- Onderneming Karolinska Development AB